We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$127B
1-Year Est. Return
46.06%
This Fund
S&P 500
This Quarter
Est. Return
+26.15%
1 Year Est. Return
+46.06%
3 Year Est. Return
+142.12%
5 Year Est. Return
+190.33%
10 Year Est. Return
+787.47%
AUM
$127B
AUM Growth
+$26.3B
(+26%)
Cap. Flow
+$9.28B
Cap. Flow
% of AUM
7.32%
Top 10 Holdings %
Top 10 Hldgs %
37.66%
Holding
3,898
New
771
Increased
1,083
Reduced
1,182
Closed
795
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.86B |
| 2 |
Costco
COST
|
+$907M |
| 3 |
AbbVie
ABBV
|
+$643M |
| 4 |
JPMorgan Chase
JPM
|
+$609M |
| 5 |
Bank of America
BAC
|
+$567M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Mercado Libre
MELI
|
+$528M |
| 3 |
Broadcom
AVGO
|
+$514M |
| 4 |
SNDK
Sandisk
SNDK
|
+$507M |
| 5 |
Marvell Technology
MRVL
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 34.91% |
| 2 | Technology | 20.64% |
| 3 | Consumer Discretionary | 9.1% |
| 4 | Healthcare | 8.21% |
| 5 | Financials | 7.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
Simulations Plus
SLP
$373M
| $7.52M | 0.01% |
410,540
-222,147
| -35% | -$3.41M |
|
1152
Vanda Pharmaceuticals
VNDA
$322M
| $7.5M | 0.01% |
1,225,996
+629,994
| +106% | +$4.12M |
|
1153
HealthEquity
HQY
$7.72B
| $7.5M | 0.01% |
83,056
+51,520
| +163% | +$4.37M |
|
1154
Rambus
RMBS
$9.42B
| $7.49M | 0.01% |
56,425
+50,899
| +921% | +$6.62M |
|
1155
BOK Financial
BOKF
$8.25B
| $7.49M | 0.01% |
53,902
+48,302
| +863% | +$6.38M |
|
1156
MacroGenics
MGNX
$275M
| $7.47M | 0.01% |
1,616,220
-409,306
| -20% | -$1.55M |
|
1157
Nexa Resources
NEXA
$1.87B
| $7.46M | 0.01% |
609,564
-632,054
| -51% | -$8.8M |
|
1158
Full Truck Alliance
YMM
$8.75B
| $7.46M | 0.01% |
918,492
-7,045,519
| -88% | -$60M |
|
1159
Wendy's
WEN
$1.45B
| $7.44M | 0.01% |
898,018
-445,531
| -33% | -$3.18M |
|
1160
International Money Express
IMXI
$435M
| $7.41M | 0.01% |
513,000
+111,600
| +28% | +$1.71M |
|
1161
US Foods
USFD
$22.3B
| $7.41M | 0.01% |
+72,453
| New | +$6.46M |
|
|
DRD
1162
DRDGold
DRD
$2.43B
| $7.39M | 0.01% |
347,168
-164,760
| -32% | -$4.45M |
|
|
AUGO
1163
Aura Minerals Inc
AUGO
$7.15B
| $7.39M | 0.01% |
117,426
-427,563
| -78% | -$33.7M |
|
1164
CALL
iShares MSCI Brazil ETF
EWZ
$8.79B
| $7.37M | 0.01% |
213,600
-1,818,000
| -89% | -$67.9M |
|
|
VSNT
1165
Versant Media Group
VSNT
$5.32B
| $7.37M | 0.01% |
204,609
-2,288,819
| -92% | -$91.9M |
|
1166
Central Garden & Pet Co Class A
CENTA
$2.21B
| $7.31M | 0.01% |
188,545
+146,368
| +347% | +$5.11M |
|
1167
IQVIA
IQV
$42.7B
| $7.28M | 0.01% |
37,666
+37,306
| +10,363% | +$6.51M |
|
1168
Aspen Aerogels
ASPN
$407M
| $7.27M | 0.01% |
1,146,707
-116,395
| -9% | -$571K |
|
1169
iShares MSCI Hong Kong ETF
EWH
$1.19B
| $7.24M | 0.01% |
+345,898
| New | +$7.96M |
|
1170
AXT Inc
AXTI
$4.56B
| $7.23M | 0.01% |
100,330
-20,058
| -17% | -$1.81M |
|
1171
Phathom Pharmaceuticals
PHAT
$763M
| $7.23M | 0.01% |
666,090
-194,602
| -23% | -$2.22M |
|
1172
RPM International
RPM
$13.1B
| $7.18M | 0.01% |
+64,561
| New | +$6.73M |
|
1173
Euronet Worldwide
EEFT
$2.69B
| $7.18M | 0.01% |
98,033
+69,294
| +241% | +$4.83M |
|
1174
The Greenbrier Companies
GBX
$1.32B
| $7.14M | 0.01% |
145,751
+81,505
| +127% | +$4.01M |
|
1175
Shinhan Financial Group
SHG
$39.2B
| $7.12M | 0.01% |
112,536
+78,815
| +234% | +$5.17M |
|
Similar funds
Marshall Wace's Q2 2026 Portfolio in Review
As of Q2 2026, Marshall Wace held 3,898 positions worth $127B, up 26% from $100B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Marshall Wace deployed $9.28B of net new capital in Q2 2026, opening 771 new positions and adding to 1,083 existing holdings. Its largest new stake was LPL Financial: 975,627 shares worth $275M.
By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 30% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $1.03B trimmed.
- Marshall Wace's largest Q2 2026 buy was LPL Financial: 975,627 shares worth $275M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.86B increase.
- Marshall Wace's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $1.03B.
- Marshall Wace fully exited Merck in Q2 2026, selling an estimated $325M.
- Marshall Wace's ten largest holdings make up 38% of its $127B portfolio in Q2 2026.
- Marshall Wace opened 771 new positions and closed 795 in Q2 2026.
- Marshall Wace's portfolio value rose 26% quarter-over-quarter to $127B.
Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.